The effects of all-trans retinoic acid on the differentiation and proliferation of immature melanocyte precursors were studied. NCC-melb4 cells are an immortal cloned cell line established from mouse neural crest cells using a single-cell cloning method. These cells were positive for tyrosinase-related protein 1, tyrosinase-related protein 2 and KIT, but were negative for tyrosinase and had no dihydroxyphenylalanine reaction. They contained only stage I melanosomes without any melanosomes in more advanced stages. After treatment with all-trans retinoic acid, many of the cells became tyrosinaseand dihydroxyphenylalanine-reaction-positive, changed from polygonal to dendritic in shape, and had stage III to IV melanosomes. These ®ndings indicate that treatment with all-trans retinoic acid induced the differentiation of NCC-melb4 cells. Reverse transcription polymerase chain reaction analysis revealed a marked increase in expression of microphthalmiaassociated transcription factor mRNA after all-trans retinoic acid treatment, suggesting that microphthalmia-associated transcription factor may be the key molecule in this event. Enhanced expression of protein kinase Ca following treatment with all-trans retinoic acid was also demonstrated. The proliferation of NCC-melb4 cells was inhibited by all-trans retinoic acid in a dose-dependent manner. Increased apoptosis after all-trans retinoic acid treatment was observed by electron microscopy, the TUNEL method, DNA fragmentation assay, and¯ow cytometry. All-trans retinoic acid upregulated caspase-3 and downregulated bcl-2. Electron microscopy showed that apoptotic cells contained melanosomes of advanced stages, suggesting that mature melanocytes may tend to undergo apoptosis after all-trans retinoic acid treatment. This study provides important clues towards understanding the roles and working mechanisms of retinoic acids in melanocyte development and melanogenesis. Key words: bcl-2, caspase-3, melanogenesis, protein kinase Ca/retinoic acid. J Invest Dermatol 118: 35±42, 2002 R etinoids, a group of chemically related molecules derived from vitamin A, regulate a large number of biologic processes in vertebrate development, cell growth, differentiation, and homeostasis (De Luca, 1991; Tabin, 1991) . These effects are thought to be mediated by nuclear receptors that belong to the superfamily of steroid/thyroid hormone receptors. There are two major classes of retinoid nuclear receptors, the retinoic acid (RA) receptors (RAR) and the retinoid X receptors (RXR). The RAR binds all-trans retinoic acid (ATRA) and 9-cis retinoic acid (9-cis RA), whereas the RXR binds only 9-cis RA (Levin et al, 1992; Allenby et al, 1993) . There are three subtypes (a, b, and g) of each RAR (Giguere et al, 1987; Petkovich et al, 1987) and RXR (Mangelsdorf et al, 1990; Hoopes et al, 1992) . These receptors are retinoidactivated transcription factors that act by binding to speci®c DNA sequences termed retinoic acid response elements (De The et al, 1989; Umesono et al, 1991) .
RA has been shown to induce differentiation and/or inhibit proliferation of many different types of tumor cells (De Luca, 1991) , including a variety of melanoma cell lines (Lotan et al, 1978; Ludwig et al, 1980; Meyskens and Fuller, 1980) . The growth inhibition of B16 mouse melanoma cells by ATRA was associated with an increase in protein kinase C (PKC) activity (Niles and Loewy, 1989) . Overexpression of PKCa in B16 melanoma cells resulted in longer doubling times, diminished anchorage-independent growth, and increased melanin production, suggesting that PKCa may be one of the key molecules involved in RA-induced melanoma differentiation (Gruber et al, 1992) . These ®ndings strongly suggest a possible role of RA in melanocyte development and melanogenesis, but little is known concerning the effect of RA on the growth and differentiation of melanocytes or melanocyte precursors.
We have established an immortal cell population of neural crest cells (NCC) from WB mice, and designated them as NCC-S4.1 cells (Kawa et al, 2000) . From the NCC-S4.1 cells, we cloned a cell line named NCC-melb4 cells using a single-cell cloning method. NCC-melb4 cells are immortal and stable in culture medium supplemented with stem cell factor (SCF), and measurement of their DNA content indicated that they retain normal DNA ploidy without malignant transformation (Ito et al, manuscript in preparation) . They appear to be immature melanocytes, as they are positive for some of the marker molecules for melanocytes, but are negative for tyrosinase and dihydroxyphenylalanine (DOPA) reaction. Using this NCC-melb4 cell line, we have now investigated the effect of ATRA on the differentiation and proliferation of immature melanocyte precursors.
MATERIALS AND METHODS
Cells and culture conditions NCC-melb4 cells were established using a single-cell cloning method from an immortal cell population (NCC-S4.1) established from NCC of WB Sl/+ or +/+ mice (Kawa et al, 2000) . The cells were grown in a humidi®ed atmosphere of 5% CO 2 and 95% air at 37°C in Eagle's modi®ed essential medium supplemented with 5% fetal bovine serum (Gibco/BRL, Grand Island, NY) and 50 ng per ml of recombinant mouse SCF (Kirin Brewery, Tokyo, Japan). ATRA (Biomol Research Laboratories, Plymouth Meeting, PA) was dissolved in ethanol at a concentration of 10 ±2 M as a stock solution, and then was added to the cell cultures at a ®nal concentration of 10 ±6 M, unless indicated otherwise. Cells treated with ATRA for 72 h were used in this study.
Immunohistochemistry, DOPA reaction, and electron microscopy The monoclonal antibody to mouse KIT (ACK2), which was generated as described previously (Nishikawa et al, 1991) , was a generous gift from Dr. Nishikawa (Kyoto University, Kyoto, Japan). Antibodies to tyrosinase (aPEP7, carboxy terminus of tyrosinase), tyrosinase-related protein 1 (TYRP1) (aPEP1, carboxy terminus of TYRP1), and tyrosinase-related protein 2 (TYRP2) (aPEP8, carboxy terminus of TYRP2) were prepared as described previously (Jimenez et al, 1991; Tsukamoto et al, 1992) and kindly supplied by Dr. Hearing (NIH, Bethesda, MD). The cells were ®xed with 95% ethanol at room temperature and treated with anti-mouse KIT (ACK2), tyrosinase, TYRP1, TYRP2, or endothelin B receptor (EDNRB) antibody (IBL, Maebashi, Japan) as described previously (Kawa et al, 2000) . For caspase-3 staining, cells were treated with anti-caspase-3 antibody (R&D Systems, Minneapolis, MN). They were then reacted with alkalinephosphatase-labeled antirat IgG (Southern Biotechnology, Birmingham, LA) or rabbit IgG (Dako, Carpinteria, CA) and developed using the New Fuchsin Substrate System (Dako). DOPA reaction, electron microscopy, and electron microscopic DOPA staining were performed as described elsewhere (Kawa et al, 2000) .
RNA extraction and reverse transcription polymerase chain reaction (RT-PCR) analysis Total RNA was extracted from the cells using an RNA isolation kit (Qiagen, Hilden, Germany) as described by the manufacturer. cDNA was prepared from 10 mg total RNA using MMLV Reverse Transcriptase (Gibco/BRL, Gaithersburg, MD). PCRs consisted of 34 cycles for tyrosinase and microphthalmia-associated transcription factor (MITF) or 35 cycles for RAR and PKC (Oxford Biomedical Research, Oxford, MI). PCRs were initiated with a``cold start'', followed by denaturation at 98°C for 10 s (tyrosinase and MITF) or at 94°C for 45 s (RAR) or at 94°C for 60 s (PKC), annealing at 60°C for 30 s (tyrosinase and MITF) or at 50°C for 30 s (RAR) or at 55°C for 60 s (PKC), and polymerization at 72°C for 60 s (tyrosinase and MITF) or at 72°C for 90 s (RAR) or at 72°C for 60 s (PKC). The primer sequences used were as follows: tyrosinase sense primer 5¢-CTATGTCATCCCCACAGGCAC-3¢; tyrosinase antisense primer 5¢-TTACCTGCCAGGAGGAGAAGA-3¢; MITF sense primer 5¢-AGT-CACTACCAGGTGCAGAC-3¢; MITF antisense primer 5¢-CTTGC-TTCAGACTCTGTGGG-3¢; RARa sense primer 5¢-CAGATGC-ACAACGCTGGC-3¢; RARa antisense primer 5¢-CCGACTGTCC-GCTTAGAG-3¢; RARb sense primer 5¢-ATGCTGGCTTCGGTC-CTC-3¢; RARb antisense primer 5¢-CTGCAGCAGTGGTGACTG-3¢; RARg sense primer 5¢-GTGGAGACCGAATGGACC-3¢; RARg antisense primer 5¢-GACAGGGATGAACACAGG-3¢; PKC (Oxford); b-actin (Promega, Madison, WI). Immunostaining and DOPA reaction of NCC-melb4 cells. Cells were cultured on cover glasses in six-well plates and were immunohistochemically stained as described in Materials and Methods. The cells were positive for TYRP1 (a), TYRP2 (b), and KIT (c), but were negative for EDNRB (d), tyrosinase (e), and DOPA reaction (f). Scale bar: 10 mm.
PCR products were resolved in 2% agarose gels containing ethidium bromide in parallel with DNA molecular weight markers.
Protein isolation and Western blot analysis Cells were harvested by scraping, collected by centrifugation, and then lyzed in cell lysis buffer (1% Triton X-100, 10 mM Tris±HCl, pH 7.4). Cell lysates were run on 10% sodium dodecyl sulfate (SDS) polyacrylamide gel. After electrophoresis, peptides on the gel were electroblotted onto nitrocellulose ®lters and the ®lters were incubated for 2 h in Trisbuffered saline (100 mM NaCl, 50 mM Tris±HCl, pH 7.4) containing 2.5 mg per ml of non-fat powdered milk (TBS-milk). The ®lters were then incubated overnight in the presence of anti-PKCa antibody (1:10,000) (Sigma, St. Louis, MO) or anti-bcl-2 antibody (1:20) (Oncogene, Cambridge, MA) and reacted with alkaline-phosphataselabeled antirabbit IgG (Dako) for 90 min. The ®lters were washed in TBS-milk and the antigens were detected with 5-bromo-4-chloro-3-indolyl phosphate (Sigma) and nitroblue tetrazodium (Sigma). 
±10
-8 M) were added to the culture medium (day 0). On days 0, 2, and 5, they were incubated with alamar Blue (Trek Diagnostic Systems, Westlake, OH) for 4 h and the¯uorescence was read on a Fluoroskan II microplate reader (Labsystems, Helsinki, Finland) .
Apoptosis assay For the detection of apoptotic cells, cells were stained with the Apop Tag in situ apoptosis detection kit (Oncor, Gaithersburg, MD) as described by the manufacturer. The Apop Tag kit is a modi®cation of the TUNEL (Tdt-mediated d-UTP nick end labeling) method that can detect DNA fragments caused by apoptosis. For DNA fragmentation assay, the cells were harvested by scraping, collected by centrifugation, and then analyzed with Apoptosis Ladder Detection kit (Wako, Osaka, Japan), as described previously (Ito et al, 1999) .
Fluorescence-activated cell sorter analysis Analysis of phosphatidylserine on the lea¯et of apoptotic cell membranes was performed using an Annexin V¯uorescence isothiocyanate (FITC) kit (Immunoteck, Marseilles, France). Double staining for FITC-Annexin V binding and for cellular DNA using propidium iodide (PI) was performed as follows. FITC-Annexin V was added to a ®nal concentration of 1 mg per ml Annexin V and PI was added to a ®nal concentration of 1 mg per ml. The mixture was incubated for 15 min in the dark at room temperature and was then measured by¯ow cytometry (FACScan, Becton Dickinson, Mountain View, CA) using program Lysys 2 (Vermes et al, 1995 
RESULTS
Characterization of NCC-melb4 cells NCC-melb4 cells were stained immunohistochemically to determine their phenotype and stage of differentiation (Fig 1) . The cells were positive for TYRP1, TYRP2, and KIT, but were negative for tyrosinase and did not react with DOPA. They were also negative for EDNRB. These ®ndings indicate that NCC-melb4 cells are not mature melanocytes but are immature melanocyte precursors. RT-PCR analysis revealed that RARa, RARb, and RARg mRNA were expressed in the cells (Fig 2) .
Differentiation of NCC-melb4 cells induced by ATRA We investigated the effects of ATRA on the differentiation of NCCmelb4 cells. As noted above, before the treatment with ATRA, the cells were negative for tyrosinase and DOPA reaction but, after 72 h of ATRA treatment, many of the cells became tyrosinase and DOPA reaction positive (Figs 3a, b) . RT-PCR analysis showed enhanced expression of tyrosinase mRNA after 72 h of ATRA treatment (Fig 3c) . Accompanying these changes, the cells dramatically altered their morphology: they changed from polygonal in shape to bipolar or dendritic (Fig 4) . Electron microscopy and electron microscopic DOPA staining are shown in Fig 5. Before treatment with ATRA, the cells contained stage I melanosomes without any in more advanced stages, and were DOPA negative. After 72 h of ATRA treatment, stage III to IV melanosomes became apparent, and positive DOPA staining was demonstrated in the Golgi areas and in melanosomes. The sum of these ®ndings strongly suggests that ATRA stimulates the differentiation of NCC-melb4 cells.
Induction of MITF and PKCa by treatment with ATRA To further investigate the molecular basis of melanocyte differentiation induced by ATRA, we tested mRNA expression of MITF and PKC. NCC-melb4 cells were incubated with or without ATRA for 72 h, and then total RNA was extracted and analyzed by RT-PCR. As shown in Fig 6(a) , a marked induction of MITF mRNA was demonstrated following treatment with ATRA, suggesting that this transcription factor may be the key molecule in this event. Enhanced expression of PKCa mRNA, but not of PKCb mRNA, was also demonstrated in the ATRA-treated cells (Fig 6b) . Western blot analysis revealed an increase in PKCa after 72 h of ATRA treatment (Fig 6c) .
Inhibitory effects of ATRA on cell proliferation is associated with increased apoptosis Next we investigated the effect of ATRA on the proliferation of NCC-melb4 cells. As shown in Fig 7, ATRA inhibited cell proliferation in a dose-dependent manner. Cells incubated with ATRA for 72 h were observed by electron microscopy (Fig 8) . Some cells had condensed nuclei with homogeneous and compacted chromatin, which are characteristics of apoptotic cells, and interestingly the majority of melanosomes in the apoptotic cells were mature melanosomes. As these ®ndings suggested that growth inhibition by ATRA might be associated with increased apoptosis, we performed the Apop Tag in situ apoptosis detection assay. As shown in Fig 9(a, b) , incubation of cells with ATRA for 72 h resulted in an increased number of apoptotic cells. We also analyzed genomic DNA extracted from the cells with or without ATRA for 72 h. DNA from the ATRAtreated cells exhibited a ladder-like pattern of oligonucleosomesized DNA fragments characteristic of apoptosis (Fig 9c) . Figure 10 shows the results of FITC-Annexin V/PI¯ow cytometry of NCC-melb4 cells incubated with or without ATRA for 1, 3, and 5 d. The experiments were repeated three times, and the average T SD of the FITC + /PI ± cell population, which represents apoptotic cells, was calculated. One day of treatment with ATRA did not cause a signi®cant increase in apoptosis. After 3 d of ATRA treatment, the apoptotic cell population was signi®cantly increased (10.53% T 0.75%) compared with the untreated controls (5.29% T 0.42%, p < 0.01). After 5 d, the apoptotic cell population was still larger (4.15% T 0.30%) in ATRA-treated cells than in untreated cells (2.19% T 0.10%, p < 0.01).
Altered expression of caspase-3 and bcl-2 after ATRA treatment To con®rm the involvement of apoptosis in ATRA-induced growth inhibition, we investigated the effect of ATRA on two apoptosis-related molecules: caspase-3 and bcl-2. On immunostaining, a marked increase in caspase-3-positive cells was demonstrated after 72 h of ATRA treatment (Fig 11) . Western blot analysis revealed a decrease in bcl-2 after 72 h of ATRA treatment (Fig 12) . These ®ndings seem to provide additional evidence that apoptosis is involved in ATRA-induced growth inhibition of NCC-melb4 cells.
DISCUSSION
Various factors, including SCF, endothelin 3, 12-O-tetradecanoylphorbol-13-acetate, and cholera toxin have been shown to stimulate the differentiation of melanocyte precursors (Murphy et al, 1992; Ito et al, 1993; Ono et al, 1998) , but the effect of RA on the differentiation of melanocyte precursors has not yet been established. NCC-melb4 cells were cloned from murine NCC in our laboratory and were immortal and stable in culture medium supplemented with SCF. As they expressed several melanocytespeci®c markers (TYRP1, TYRP2, and KIT) but were negative for tyrosinase and did not produce melanin, NCC-melb4 cells were thought to be immature melanocyte precursors. In this study, we showed that NCC-melb4 cells treated with ATRA became tyrosinase and DOPA reaction positive, changed in shape from polygonal to dendritic, and contained melanosomes at advanced stages. These ®ndings indicate that ATRA promotes the differentiation of melanocyte precursors, and also suggest a possible role for RA in melanocyte development in vivo.
In melanoma cells, differentiation induced by ATRA is closely associated with enhanced expression of PKCa (Gruber et al, 1992; . In our experiments using NCC-melb4 cells, induction of PKCa mRNA and protein by ATRA was also observed. Thus, PKCa seems to be commonly involved in the biologic effects of ATRA in melanoma cells and in melanocyte precursors.
MITF is the human homolog of the mouse microphthalmia (mi) gene product, which was identi®ed as a novel transcription factor of the basic helix±loop±helix (bHLH) leucine zipper protein family (Hodgkinson et al, 1993; Hughes et al, 1993; Tachibana et al, 1994) . MITF is able to direct melanocyte-speci®c transcription of the tyrosinase and TYRP1 genes (Yasumoto et al, 1994 (Yasumoto et al, , 1997 and is thought to be involved in the differentiation and maintenance of melanocytes (Tachibana, 1997 (Tachibana, , 2000 . As tyrosinase expression is upregulated by ATRA it was of interest to determine whether ATRA alters MITF expression in NCC-melb4 cells. RT-PCR analysis revealed that MITF mRNA expression was markedly increased by ATRA treatment, which suggests that MITF, as well as PKCa, may be the key factor in ATRA-induced melanocyte differentiation. This is the ®rst study showing the induction of MITF by treatment with ATRA.
We also showed that ATRA inhibited the proliferation of NCCmelb4 cells and induced apoptosis. Apoptosis is a distinctive form of cell death that can result in the deletion of speci®c cell populations during physiologic processes such as embryonal development and the clonal selection of lymphocytes (Kerr et al, 1972; Wyllie et al, 1980) . Several methods have been developed to detect apoptosis. The nick end labeling method of DNA fragments achieved by the TUNEL method, morphologic observations by electron microscope, gel electrophoresis of genomic DNA ladder-like fragments, and¯ow cytometry of FITC-Annexin V/PI (Vermes et al, 1995) are generally recognized and adopted as diagnostic bases for apoptosis. Fragmentation occurs in each unit of nucleosome in chromatin DNA during apoptosis. After the cleaving of a large fragment of 50±200 kbp, oligonucleosome size (= 180 bp) fragmentation occurs (Brown et al, 1993) . In this study, we demonstrated that apoptosis was increased following treatment with ATRA using electron microscopy, the TUNEL method, DNA fragmentation assay, and¯ow cytometry.
Caspases have been implicated in the execution phase of apoptosis (Nicholson and Thornberry, 1997) and are shown to cleave speci®c substrates as the cell begins to present the characteristic morphologic changes of apoptosis. Caspase-3 was shown to cleave a wide range of cytoplasmic and nuclear proteins, which suggests an important role for this protease in apoptosis (Germain et al, 1999) . In this study, we showed a marked increase in caspase-3-positive cells after ATRA treatment. Bcl-2 has been shown to prolong cell survival and block apoptosis (Reed, 1994) . Western blot analysis revealed that bcl-2 expression was markedly decreased by ATRA treatment. These ®ndings seem to provide additional evidence for the involvement of apoptosis in ATRAinduced growth inhibition of NCC-melb4 cells. The observation that many of the apoptotic cells contained mature melanosomes in their cytoplasm may indicate that mature and differentiated melanocytes apoptose after ATRA treatment. Therefore it is conceivable that ATRA has bifunctional effects on melanocytes: it may stimulate the differentiation of melanocyte precursors by inducing tyrosinase, and it may remove terminally differentiated melanocytes through apoptosis. Regarding the effect of RA on melanogenesis, con¯icting data have been published. Melanogenesis in melanoma cells can be modulated positively or negatively by RA (Lotan and Lotan, 1980; Edward et al, 1988; Orlow et al, 1990) . In vivo studies have revealed that topical application of RA can stimulate melanin production in mice (Ho et al, 1992; Welsh et al, 1999) and in humans (Talwar et al, 1993) , but, in contrast, several clinical studies have shown that topical application of RA can improve hyperpigmented skin lesions (Rafal et al, 1992; Bulengo-Ransby et al, 1993; Grif®ths et al, 1993) . The bifunctional effects of ATRA suggested by our study provide clues to interpret these apparently contradictory ®ndings; thus, ATRA may stimulate melanogenesis by inducing melanocyte differentiation, and may at the same time inhibit melanogenesis by removing mature melanocytes through apoptosis. The ®ndings reported in this study provide some important viewpoints to understand the roles and working mechanisms of RA in melanocyte development and melanogenesis.
